Indication
Alimta is used for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC). Alimta is also used for malignant pleural mesothelioma (MPM), which is a cancer that affects the inside lining of the chest cavity and cannot be treated with surgery.
Note
Precaution
- Premedication regimen: Prior initiate supplementation with oral folic acid and intramuscular vitamin B12, to reduce the severity of hematologic and gastrointestinal toxicity of Alimta.
 - Alimta is a prescription drug and should be used under proper medical guidance and advice.
 - Alimta may cause bone marrow suppression
 





